BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-271@pharmaconomics
DTSTAMP:20260707T030038Z
DTSTART;VALUE=DATE:20260317
DTEND;VALUE=DATE:20260318
SUMMARY:ALDX CRL — reproxalap
DESCRIPTION:An FDA complete response letter on reproxalap for dry eye disease is in focus around Mar 17\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1341235/000119312526109511/aldx-ex99_1.htm\n\nTrack it: https://pharmaconomics.com/e/271
URL:https://pharmaconomics.com/e/271
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ALDX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR